Company profile · Sponsor
ISTA
ISTA Pharma Limited
- Pipeline
- 7
- Drugs
- 0
- Patents
- 0
Quick answer
ISTA (ED77F4B) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..
Company facts
Pipeline (7)
Search pipeline →-
-, Sodium butyrate 1,1 g/L sol prep
ISTA
Hirschsprung's disease
1 trial -
KARDEGIC 75 mg, poudre pour solution buvable en sachet-dose, CLOPIDOGREL, CLOPIDOGREL
ISTA
chronically occluded coronary artery
1 trial -
MYCOHYDRALIN 500 mg, capsule vaginale, FLAGYL 500 mg, comprimé pelliculé, ZITHROMAX 250 mg, comprimé pelliculé, ROCEPHINE 1 g/3,5 ml, poudre et solvant pour solution injectable (IM), GRANUDOXY 100 mg, comprimé pelliculé sécable
ISTA
Bacterial vaginosis, High risk preterm birth pregnancy, Vaginal flora abnormalities
1 trial -
NICOTINAMIDE, cellulose microcristalline
ISTA
Acute kidney injury
1 trial -
Randomized control trial comparison between intra-articular infiltrations of PRP, MFAT, and PRP-MFAT in the treatment of symptomatic knee osteoarthritis.
ISTA
knee osteoarthritis
1 trial -
placebo ketamine inj prep, KETAMINE RENAUDIN 10 mg/ml, solution injectable
ISTA
Traumatism
1 trial -
Inlyta 1 mg film-coated tablets, Inlyta 3 mg film-coated tablets, CELLTOP 50 mg, capsule molle, ETOPOSIDE VIATRIS 20 mg/ml, solution à diluer pour perfusion
ISTA
Ependymoma, Medulloblastoma
1 trial
Frequently asked questions
What is ISTA?
ISTA (ED77F4B) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..
What pipeline programs does ISTA sponsor?
We track 7 ClinicalTrials.gov-linked programs for ISTA, including -, Sodium butyrate 1,1 g/L sol prep and 6 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does ISTA company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.